Cannabis & Health Insurance Switzerland — who pays what in 2026
Medical cannabis in Switzerland can cost several hundred to over 1,000 CHF per month. Here's which insurers pay when — and how to plan realistically.
TL;DR: Basic insurance: only Sativex® (MS spasticity) and Epidyolex® (rare epilepsies) are on the specialities list. Other preparations: virtually never via basic — only case-by-case under Art. 71a/b HIO. Supplementary: some plans reimburse partially, usually with prior authorisation. Realistic: plan to pay yourself. CannabisClub members: 50 CHF consultation instead of 190 CHF and long-term savings.
Basic insurance — when it pays
On the FOPH specialities list: Sativex® (MS spasticity) and Epidyolex® (Lennox-Gastaut, Dravet). That's it.
Other preparations — flower, extracts, dronabinol, magistral oils — not covered. Case-by-case possible under Art. 71a/71b HIO: rare and serious illness, no effective alternative, plausible efficacy, prior authorisation.
In reality almost always refused for chronic pain, ADHD or sleep. Much better chances in palliative care, severe neurology or complex oncology.
Supplementary — the more realistic route
Some outpatient supplementary plans reimburse cannabis partially — often 50–90% up to an annual cap (500–3,000 CHF).
Condition: cannabis prescribed by a licensed doctor and dispensed at a Swiss pharmacy. Insurance usually requires a medical certificate and prior authorisation.
Note: recently taken-out supplementary plans have waiting periods (3–24 months) and exclude pre-existing diagnoses. Switching 'for cannabis' rarely works.
How to file a prior-authorisation request
1. Your doctor writes a structured request: diagnosis, history, documented therapy failure, cannabis indication.
2. Attachments: medical reports, medication history, progress notes. More complete = better.
3. Sent to the insurer's medical officer. Processing 2–8 weeks.
4. If refused: appeal within 30 days, optionally with a second opinion from a scientific society.
5. Second refusal: appeal to the cantonal social insurance court (heavy, reserve for strong cases).
How CannabisClub members cut costs
Consultation: 50 CHF flat instead of 190 CHF. Over 4 consultations/year, ~560 CHF saved.
Cannabis: while the law requires it, dispensing runs through the pharmacy. For CBD products (parallel management of anxiety, sleep, tension), members pay wholesale prices — 1–2 CHF/g instead of 5–8 CHF/g.
Outlook: once the legal framework allows (likely after 2028), CannabisClub plans direct THC access for members at wholesale prices — potentially 3–5 CHF/g instead of 10–15 CHF/g at the pharmacy.
FAQ
Does basic insurance cover medical cannabis?
Only Sativex® (MS) and Epidyolex® (rare epilepsies). Other preparations: virtually never, except individual Art. 71a/b HIO request — rarely accepted.
Which supplementary plan reimburses prescribed cannabis?
Several outpatient supplementary plans reimburse partially (50–90%) up to an annual cap. Medical certificate and prior authorisation usually required. Compare via Comparis.
Cost of medical cannabis without reimbursement?
10–15 CHF/g for flower, 100–250 CHF per extract bottle, 100 CHF for 30 ml dronabinol. Typical monthly cost: 300–1,500 CHF.
Can I switch insurers to be reimbursed?
Basic: no, same rules for all. Supplementary: theoretically yes, but waiting periods and exclusions rarely make it worthwhile for an existing patient.
Chances of success under Art. 71a/b HIO?
Low for chronic pain and sleep. Much better in palliative care, severe neurology and complex oncology — the quality of the file makes the difference.